Sage Therapeutics Announces First Quarter 2022 Financial Results and Highlights Pipeline and Business Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. RH
3. NVDA
4. SPCX
5. USO
6. RKLB
7. NDAQ
8. MH
9. SILEF
10. COGT

Go back to Sage Therapeutics Announces First Quarter 2022 Financial Results and Highlights Pipeline and Business Progress

SAGE Therapeutics (SAGE) Reports Q1 Net Loss of $122.1M

May 3, 2022 6:40 AM EDT

SAGE Therapeutics (NASDAQ: SAGE) reported Q1 net loss of $122.1 million. Revenue for the quarter came in at $1.6 million versus the consensus estimate of $3.21 million.

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.

... More